Pan-cancer analysis revealed that EIF3M exhibited significantly elevated gene activity scores across 15 tumor types, including BLCA, BRCA, CHOL, COAD, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LIHC, LUAD, PRAD, READ, and UCEC. The gene discussed is EIF3M; the disease is neoplasm.